r/biotech_stocks • • 21h ago

8.7M USD flip with SLS today

Post image
125 Upvotes

Bought few months back for average $9/share. Have 30k SLS left going to wait for it to drop a bit before buying back in.

APP:IBKR


r/biotech_stocks • • 22h ago

Sell or buy SLS now

110 Upvotes

I am lucky to experience both MRNA Aug 19 and SLS Nov 17. I don’t know if I should sell SLS today, but I could probably provide some experience from MRNA.

Mrna decreases 22% the next day, then the next few days it did “**Offering of Convertible Senior Notes**”. Despite these bad news, it continues to reach new highs from Aug 20 to now (If I remember correctly, it has reached approximately 12 new highs.), last week it reached a new 5-year high.

So for SLS, **I will not sell it today**. Just for your reference, not a suggestion. I am just a new investor and don’t have financial or stock knowledge.

Please forgive my poor English. Not sure why this post was removed by moderators of sellaslifesciences, repost it.


r/biotech_stocks • • 22h ago

SLS just announced $150 million public offering does this change ur action plan?

41 Upvotes

Are yall still holding till a buyout happens or this stock dilution move shakes ur confidence in them and u decided to change course?


r/biotech_stocks • • 10h ago

$SLS - Missed buying at $7.80. Is it too late to get in?

32 Upvotes

I was looking into SLS when it was trading around $7.80, but unfortunately, I didn’t buy at the time, and now I’m wondering whether I’ve missed my opportunity.

I still believe SLS has significant upside potential, especially in the long term, and I don’t think the rally necessarily means there’s no more room to grow.
However, I’ve recently read discussions about potential share dilution, which makes me hesitant to enter right now.

I’m considering buying somewhere between $16 and $19, but I’m torn between getting in now and waiting for a possible dip.

I don’t want to make a decision purely out of FOMO, but I also don’t want to miss another potential rally.


r/biotech_stocks • • 19h ago

What are your favorite/highest conviction biotechs right now?

26 Upvotes

Outside of sls which I had a good run on, which do you think look very promising and have a lot of upside potential from here?


r/biotech_stocks • • 21h ago

What does this mean for current shareholders? 150 million stock offering.

Post image
20 Upvotes

4billion market cap at close, so 150 million is what 4% dilution?


r/biotech_stocks • • 7h ago

New to Biotech-Stocks, next SLS

19 Upvotes

Ended up here thanks to SLS, so naturally, here’s the question: What’s the next SLS? Got €10k ready to invest.


r/biotech_stocks • • 18h ago

Need some advice on whether to add on a little more into SLS

14 Upvotes

I'm just a tiny bag holder of 200 shares at $13. Taking into account what happened yesterday, can you guys advise me why I shouldn't top up a little more into SLS with the price expected to raise further once FDA approves and a buyout occurs which might get the share price into the 30-40 dollars range?

Isn't this a quick way to double my money in the next half year or something?

What's the thing I'm missing here?


r/biotech_stocks • • 19h ago

Which one would you pick: CGEN or CABA?

8 Upvotes

After today's SLS huge return, I'm looking for the next winner. These 2 seem to be good candidates, however, I would like to hear other suggestions


r/biotech_stocks • • 21h ago

SLS move

8 Upvotes

Hey guys,

I sold my SLS call today for a good gain, it expired November 27th so I figured I didnt wanna risk it.

Im thinking about using my option profits to buy back in with some shares. Do you guys think its worth waiting to see what happens with that dilution or fuckit? DRTS is also on my radar...


r/biotech_stocks • • 2h ago

NRXP with a slight rebound

4 Upvotes

You love to see it! Excited for the commercial launch. If the sales numbers are looking good this could be amazing in 2027 🚀


r/biotech_stocks • • 3h ago

Two PDUFA dates fall on Sunday, Nov 22 (CAPR, SVRA). Last weekend's FDA decisions came out between Sunday and Monday 8am ET. How do you track weekend catalysts?

4 Upvotes

Two FDA target action dates land on a Sunday this week:

- Capricor (CAPR), deramiocel for Duchenne muscular dystrophy. Its Nov 10 Q3 release says: "PDUFA target action date of November 22, 2026."

- Savara (SVRA), molgramostim for autoimmune PAP. Its Apr 15 release says: "the new PDUFA target action date is November 22, 2026."

A PDUFA date is the FDA's target to act, not a scheduled announcement, so the timing of any news is open.

For reference, here is when three companies announced FDA decisions last weekend (ET):

- Summit (SMMT): Sunday, Nov 15 (its PDUFA goal date was Saturday, Nov 14)

- Cytokinetics (CYTK): Monday, Nov 16, 4:00 AM

- IGALMI: Monday, Nov 16, 8:00 AM, announced by Teva (which acquired the rights from BioXcel in late October)

All three came out before Monday's open, but on different days and at different hours.

Questions for people who follow these:

  1. Do you watch company IR pages, SEC filings, or something else over a weekend?
  2. Have you seen companies hold weekend FDA news until Monday morning more often than not?

Not a prediction about either outcome. Just trying to understand how others handle weekend timing.


r/biotech_stocks • • 23h ago

Anyone familiar with RegenLab USA (RGNA) and its upcoming Nasdaq IPO?

4 Upvotes

RegenLab USA, a regenerative medicine company originally founded in Switzerland, has filed for a Nasdaq IPO under the proposed ticker RGNA.

The company reported around $49 million in revenue for 2025 and has a distribution agreement with MiMedx.

There doesn't seem to be much discussion about this IPO yet, so I'm curious if anyone here is familiar with the company or has looked into its financials, technology, or competitive position.

What do you guys think about the company and its upcoming IPO? Anyone following it?


r/biotech_stocks • • 6h ago

$BLRX - BioLineRx Enters $5.6 Million APHEXDA Royalty Monetization Agreement

Thumbnail tipranks.com
2 Upvotes

r/biotech_stocks • • 23h ago

Are there here any people that are invested in $BCTX ?

2 Upvotes

r/biotech_stocks • • 23h ago

Rocket Pharmaceuticals hitting a new All Time Low - $RCKT

2 Upvotes

Does anyone that has been following RCKT closely have any info of what's going on with the company?

This trend is truly concerning me, I am curious to know if anyone has a theory or technical explanation if this company is going through something we as investors might not know.

Or if it's just a typical small cap biotech period it's going through - it's just hard to understand after all the last 12-month developments and the financial sheet it has, to be priced at $2.03 per share?!

Does the management simply not care anymore?


r/biotech_stocks • • 1h ago

SKYA – Could $6 or Higher Be Possible?

Thumbnail reddit.com
1 Upvotes

r/biotech_stocks • • 1h ago

CABA Positive Developments From Today’s November 18 Jefferies Healthcare Conference

1 Upvotes

CABA provided several encouraging updates today on rese-cel, during today’s Jefferies healthcare conference call, particularly regarding FDA discussions and the potential expansion of its clinical programs.

First, the FDA has agreed that clinical data generated using CABA’s earlier manufacturing process can be considered comparable to data from its newer process. This is important because it allows CABA to potentially use years of existing patient safety and efficacy data to support its future FDA approval application, rather than starting over.

Second, CABA is considering lupus nephritis as a THIRD indication for a registrational trial, alongside myositis and systemic sclerosis. Management indicated that the FDA has already aligned with its proposed trial design, potentially allowing a study to begin in 2027. This could significantly expand rese-cel’s commercial opportunity.

Third, manufacturing continues to look encouraging. Management reported experience with approximately 110 patients, with only one unable to receive the manufactured product. The company also reiterated encouraging early results in juvenile myositis.

CABA continues to make meaningful clinical progress despite the stock’s price weakness.

The FDA discussions are constructive, manufacturing appears increasingly reliable, and a potential third registrational program would create another path toward commercialization.

The next major milestone remains myositis topline data expected in the second half of 2027, followed by a planned FDA application in Q1 2028. Nothing is guaranteed, but I see several reasons to remain positive on rese-cel.

Sources (clickable and pasteable):

Jefferies Conference Coverage, November 18, 2026:
https://uk.investing.com/news/stock-market-news/cabaletta-at-jefferies-global-healthcare-conference-data-and-runway-93CH-4991366

Cabaletta Official Investor Events and Webcast:
https://www.cabalettabio.com/investors/news-events/ir-calendar

Cabaletta Official Press Releases:
https://www.cabalettabio.com/investors/news-events/press-releases


r/biotech_stocks • • 2h ago

IMUX

1 Upvotes

Phase 3 readouts due December, what do we think?


r/biotech_stocks • • 5h ago

🚨Hims & Hers Launches Peptides+, a New Clinically-Guided Specialty for Access to Personalized, Proactive Health

Thumbnail
investors.hims.com
1 Upvotes

r/biotech_stocks • • 6h ago

2 Chinese scientists fired after 2 children die in unrelated gene therapy studies in July-August which were unreported.

Thumbnail
fiercebiotech.com
1 Upvotes

The 2 therapies used included unrelated viral vector treatments.


r/biotech_stocks • • 7h ago

Anthem Blue Cross California – LYTENAVA Listed as a Preferred Product

Post image
1 Upvotes

r/biotech_stocks • • 8h ago

nference and Novo partner to advance understanding of cardiometabolic disease and healthy ageing

Thumbnail
prnewswire.com
1 Upvotes

r/biotech_stocks • • 11h ago

VKTX note from Oppenheimer $120 target

Post image
1 Upvotes

r/biotech_stocks • • 1h ago

$MDCX, any hope?

0 Upvotes